Metastatic Uveal Melanoma Hla A 02 01 Positive clinical trials

Explore recruiting metastatic uveal melanoma hla a 02 01 positive clinical trials.

Recruiting metastatic uveal melanoma hla a 02 01 positive studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Uveal Melanoma Hla A 02 01 Positive trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Hepatic radiotherapy added to standard of care for the treatment of HLA A*02:01 positive Metastatic Uveal Melanoma patients

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Metastatic Uveal Melanoma Hla A 02 01 Positive trials by city

Metastatic Uveal Melanoma Hla A 02 01 Positive in Toronto Metastatic Uveal Melanoma Hla A 02 01 Positive in Vancouver Metastatic Uveal Melanoma Hla A 02 01 Positive in Montreal Metastatic Uveal Melanoma Hla A 02 01 Positive in Calgary Metastatic Uveal Melanoma Hla A 02 01 Positive in Edmonton Metastatic Uveal Melanoma Hla A 02 01 Positive in Ottawa Metastatic Uveal Melanoma Hla A 02 01 Positive in Winnipeg Metastatic Uveal Melanoma Hla A 02 01 Positive in Quebec City Metastatic Uveal Melanoma Hla A 02 01 Positive in Hamilton Metastatic Uveal Melanoma Hla A 02 01 Positive in Kitchener Metastatic Uveal Melanoma Hla A 02 01 Positive in London Metastatic Uveal Melanoma Hla A 02 01 Positive in Halifax Metastatic Uveal Melanoma Hla A 02 01 Positive in New York Metastatic Uveal Melanoma Hla A 02 01 Positive in Los Angeles Metastatic Uveal Melanoma Hla A 02 01 Positive in Chicago Metastatic Uveal Melanoma Hla A 02 01 Positive in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease